Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Total Debt (2016 - 2025)

Avanos Medical (AVNS) has disclosed Total Debt for 12 consecutive years, with $10.2 million as the latest value for Q4 2025.

  • Quarterly Total Debt rose 8.51% to $10.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.2 million through Dec 2025, up 8.51% year-over-year, with the annual reading at $10.2 million for FY2025, 8.51% up from the prior year.
  • Total Debt hit $10.2 million in Q4 2025 for Avanos Medical, up from $9.4 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $232.5 million in Q4 2022 to a low of $4.7 million in Q2 2022.
  • Historically, Total Debt has averaged $29.8 million across 5 years, with a median of $9.4 million in 2024.
  • Biggest five-year swings in Total Debt: soared 78.85% in 2022 and later tumbled 96.3% in 2023.
  • Year by year, Total Debt stood at $130.0 million in 2021, then skyrocketed by 78.85% to $232.5 million in 2022, then crashed by 96.3% to $8.6 million in 2023, then grew by 9.3% to $9.4 million in 2024, then grew by 8.51% to $10.2 million in 2025.
  • Business Quant data shows Total Debt for AVNS at $10.2 million in Q4 2025, $9.4 million in Q3 2025, and $9.4 million in Q2 2025.